ArticleArthroscopy techniques2026
Video-Assisted Intralesional Curettage for Invasive Nonmalignant Giant Cell Tumors.
Article in Arthroscopy techniques, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Giant cell tumor of bone is a locally aggressive benign neoplasm with a strong tendency for local recurrence after surgical treatment. Intralesional excision and curettage is preferred in most cases to maximize tumor removal while preserving the affected joint. The present technical note describes Video-Assisted Intralesional Curettage of Invasive Nonmalignant Giant cell tumors, a technique in which intracavitary 30° arthroscopic visualization is integrated with extended intralesional curettage. After the creation of a cortical window for Campanacci grade 2 lesions or the use of the existing cortical defect for grade 3 lesions, the arthroscope is introduced and rotated through 360° to identify residual pigmented tumor in recesses not visible to the unaided eye. Targeted recurettage, high-speed burring, and monopolar electrocautery on spray mode are then applied under direct video visualization, followed by pulsed saline lavage and reconstruction with polymethyl methacrylate cementation, with the aim of reducing residual microscopic disease at every step.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.